Lehrstuhl für Strahlentherapie

Principles of artificial intelligence in radiooncology (2024) Huang Y, Gomaa A, Höfler D, Schubert P, Gaipl U, Frey B, Fietkau R, et al. Journal article, Original article Task-Specific Data Preparation for Deep Learning to Reconstruct Structures of Interest from Severely Truncated CBCT Data (2024) Huang Y, Fan F, Gomaa A, Maier A, Fietkau R, Bert C, Putz F Conference contribution Improving the safety of radiotherapy treatment processes via incident-driven FMEA feedback loops (2024) Kornek D, Lotter M, Szkitsak J, Dürrbeck C, Karius A, Ott O, Brandl C, Bert C Journal article, Original article Outcomes of I-125 Low-Dose-Rate Brachytherapy in Patients with Localized Prostate Cancer: A Comprehensive Analysis from a Specialized Tertiary Referral Center (2024) Schubert P, Strnad V, Höfler D, Schweizer C, Putz F, Lotter M, Kreppner S, et al. Journal article End-to-end testing for stereotactic radiotherapy including the development of a MULTI-MODALITY phantom (2024) Shariff M, Grigo J, Masitho S, Brandt T, Weiß A, Lambrecht U, Stillkrieg W, et al. Journal article, Original article An Experimental Survey of Incremental Transfer Learning for Multicenter Collaboration (2024) Huang Y, Bert C, Gomaa A, Fietkau R, Maier A, Putz F Journal article, Original article Comprehensive Multimodal Deep Learning Survival Prediction Enabled by a Transformer Architecture: A Multicenter Study in Glioblastoma (2024) Gomaa A, Huang Y, Hagag A, Schmitter C, Höfler D, Weissmann T, Breininger K, et al. Journal article, Original article Multicenter privacy-preserving model training for deep learning brain metastases autosegmentation (2024) Huang Y, Khodabakhshi Z, Gomaa A, Schmidt M, Fietkau R, Guckenberger M, Andratschke N, et al. Journal article, Original article Effective Radiosensitization of HNSCC Cell Lines by DNA-PKcs Inhibitor AZD7648 and PARP Inhibitors Talazoparib and Niraparib (2024) Mentzel J, Hildebrand L, Kuhlmann L, Fietkau R, Distel L Journal article Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R (2024) Filippi AR, Bar J, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, et al. Journal article